At DENALI THERAPEUTICS, I am dedicated to develop breakthrough therapies for neurodegenerative diseases (Alzheimer’s, Parkinson’s, ALS, others).  

I am using insight from human genetics to reveal new targets and pathways, and the latest molecular, cellular, and imaging techniques to investigate the underlying biology of neurodegeneration.  I work closely with medicinal chemists, biologists, and pathway leaders to identify relevant biomarkers and biological pathways that will improve our understanding, diagnosis, and treatment of neurodegenerative diseases.

- Albert Einstein

Contact me:

The most beautiful thing we can experience is the mysterious—it is the source of all true art and science.

Greg Potter



Company: Denali Therapeutics
Location: South San Francisco